Experiment 1286547

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationRODRIGUEZ,M: RINGSTAD,L: SCHAFER,P: JUST,S: HOFER,HW: MALMSTEN,M: SIEGEL,G:. (2007). REDUCTION OF ATHEROSCLEROTIC NANOPLAQUE FORMATION AND SIZE BY GINKGO BILOBA (EGB 761) IN CARDIOVASCULAR HIGH-RISK PATIENTS.. 192(2)
Amount utilized
Compound isolated
DiseaseA COMMERCIAL PRODUCT, ROKAN, WAS USED.
Dose amount240.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES